Aurobindo Pharma USA Inc. is recalling 210,520 units of various prescription medications, including Acetaminophen/Codeine, Gabapentin, Simvastatin, and Mirtazapine, due to a manufacturing defect. These products were produced in an area where water leakage was observed, which violates Good Manufacturing Practice (CGMP) standards and may compromise the safety or quality of the medicine. Consumers should check their medicine cabinets for the specific lot numbers and expiration dates listed and contact their healthcare provider for guidance on alternative medications.
Manufacturing drugs in a facility with active water leakage introduces a significant risk of microbial contamination or degradation of the active ingredients. This can lead to decreased effectiveness of the medication or potential infection, especially for patients with weakened immune systems.
Contact healthcare provider and return product for refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.